Valuation : Kenvue Inc.

Market Cap 36.4B 31.32B 29.47B 26.92B 50.36B 3,437B 50.5B 348B 135B 1,763B 137B 134B 5,680B P/E 2026 *
19.9x
P/E 2027 * 17.3x
Enterprise Value 43.5B 37.43B 35.21B 32.17B 60.18B 4,107B 60.34B 416B 161B 2,107B 163B 160B 6,788B EV / Sales 2026 *
2.79x
EV / Sales 2027 * 2.69x
Free-Float
98.88%
Yield 2026 *
4.45%
Yield 2027 * 4.55%
1 day-0.82%
1 week-1.72%
Current month-0.21%
1 month-3.63%
3 months+11.61%
6 months+3.57%
Current year+9.22%
1 week 18.71
Extreme 18.71
19.18
1 month 18.65
Extreme 18.65
19.7
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.69
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%-1.72%-8.28%-16.67% 36.4B
-0.25%+1.90%-7.97%-3.89% 341B
+0.63%-0.27%-11.81%+5.16% 138B
-1.17%-1.90%+6.41%+22.33% 71.82B
+0.58%-1.77%-25.94%-21.22% 48.77B
+3.03%+0.57%+18.89%-35.44% 36.49B
-1.58%-3.43%+1.76%+23.19% 20.65B
+0.03%-4.95%-22.71%-36.90% 19.37B
-0.33%-2.86%+6.29%+7.33% 19.38B
-0.23%-4.88%-31.16%-12.67% 9.53B
Average -0.01%-2.28%-7.45%-6.88% 74.16B
Weighted average by Cap. -0.00%+0.16%-7.21%-2.91%

Financials

2026 *2027 *
Net sales 15.6B 13.42B 12.63B 11.53B 21.58B 1,472B 21.64B 149B 57.9B 755B 58.56B 57.28B 2,434B 15.97B 13.74B 12.93B 11.81B 22.09B 1,507B 22.15B 153B 59.27B 773B 59.96B 58.65B 2,492B
Net income 1.83B 1.57B 1.48B 1.35B 2.53B 173B 2.54B 17.51B 6.79B 88.65B 6.87B 6.72B 286B 2.11B 1.82B 1.71B 1.56B 2.92B 199B 2.93B 20.21B 7.84B 102B 7.93B 7.76B 330B
Net Debt 7.1B 6.11B 5.75B 5.25B 9.82B 670B 9.85B 67.9B 26.35B 344B 26.65B 26.07B 1,108B 6.52B 5.61B 5.28B 4.82B 9.02B 616B 9.04B 62.37B 24.2B 316B 24.48B 23.95B 1,017B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-04 US$18.74 -1.11% 26,747,484
26-09-03 US$18.95 -0.94% 18,570,436
26-09-02 US$19.13 +2.03% 19,692,893
26-09-01 US$18.75 -0.69% 21,754,679
26-08-31 US$18.88 -1.51% 27,072,043
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.95USD
Average target price
19.50USD
Spread / Average Target
+2.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock